Detalles de la búsqueda
1.
Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study.
BMJ Open
; 11(4): e037457, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849844
2.
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 626, 2020 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641154
Resultados
1 -
2
de 2
1
Próxima >
>>